돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 1803949생성일: 2026년 10월 25일

Methylboronic Acid → 1-(2-Ethyl-4-methylphenyl)-4-(toluene-4-sulfonyl)piperazine

https://huagongshe.com/reaction/1803949

반응식

참여 물질

역할이름HCID투입량
반응물Methylboronic AcidHCID 139377—
반응물Potassium FluorideHCID 522689—
반응물2-Dicyclohexylphosphino-2',6'-dimethoxybiphenylHCID 11269872—
반응물1-(4-Bromo-2-ethylphenyl)-4-(toluene-4-sulfonyl)piperazineHCID 67381335—
촉매palladium(II) acetateHCID 167845—
용매WaterHCID 962—
용매TetrahydrofuranHCID 8028—
생성물1-(2-Ethyl-4-methylphenyl)-4-(toluene-4-sulfonyl)piperazineHCID 67381016114.2%

반응 단계

A mixture of 4-bromo-2-ethylaniline (1.4 mL), diisopropylethylamine (4.4 mL) and N,N-bis(2-chloroethyl)-4-methylbenzenesulfonamide (3 g) was refluxed for 5 hr. After cooling, the solvent was evaporated, and the residue was purified by column chromatography (chloroform) to give 1-(4-bromo-2-ethylphenyl)-4-(toluene-4-sulfonyl)piperazine (3 g). To a mixture of 1-(4-bromo-2-ethylphenyl)-4-(toluene-4-sulfonyl)piperazine (3 g), methylboronic acid (1.2 g), palladium acetate (112 mg), 2-dicyclohexylphosphino-2′,6′-dimethoxybiphenyl (411 mg) and potassium fluoride (2.3 g) was added tetrahydrofuran (30 mL), and the mixture was refluxed for 8 hr. After cooling, water was added to the reaction mixture, and the mixture was extracted with ethyl acetate. The organic layer was washed with saturated brine, and the solvent was evaporated. The residue was purified by column chromatography (chloroform) to give 1-(2-ethyl-4-methylphenyl)-4-(toluene-4-sulfonyl)piperazine (2.9 g). A mixture of 1-(2-ethyl-4-methylphenyl)-4-(toluene-4-sulfonyl)piperazine (2.9 g), hydrobromic acid (16 mL) and acetic acid (16 mL) was refluxed for 8 hr. After cooling, the reaction mixture was alkalified with 1N aqueous sodium hydroxide solution, and the mixture was extracted with chloroform. The organic layer was washed with saturated brine, and the solvent was evaporated. 4N hydrogen chloride/ethyl acetate (3 mL) was added and the mixture was filtered to give 1-(2-ethyl-4-methylphenyl)piperazine hydrochloride (1.7 g). To a mixture of 4-bromo-2-methanesulfonylbenzoic acid (1.1 g), 1-(2-ethyl-4-methylphenyl)piperazine hydrochloride (963 mg) and 4-(4,6-dimethoxy[1.3.5]triazin-2-yl)-4-methylmorpholinium chloride hydrate (DMT-MM) (1.5 g) were added chloroform (6 mL), methanol (6 mL) and N-methylmorpholine (440 μL), and the mixture was stirred at room temperature overnight. After evaporation of the solvent, the residue was purified by column chromatography (chloroform) to give the title compound (1.8 g).

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US08354401B2
출처 데이터셋uspto-grants-2013_01
ORD IDord-7a4a28016fcd43bb9d14c6fbc71b0880
출처 메모uspto-grants-2013_01